Category: Abbott Laboratories
Hospital system and insurance provider alliance SharedClarity awards its 1st purchasing contracts to Medtronic and Abbott for bare metal and drug-eluting stents.
Abbott closes down a Puerto Rico manufacturing facility, marking the 3rd reported workforce cuts in the last week alone.
Abbott (NYSE:ABT) is reportedly shutting down a Puerto Rico manufacturing plant, with an unspecified number of employees slated for termination.
More rumors surface that Abbott Labs is conducting January layoffs, this time at facilities in Ireland.
More rumors surfaced that Abbott (NYSE:ABT) is looking to make cuts in its workforce, with an Irish paper reporting that nearly 80 employees will be cut from 3 local plants.
Abbott Labs conducted an unspecified number of layoffs at its Lake County, Ill., headquarters in apparent efforts to cut costs, according to local reports.
Updated January 28, 2014, at 3:30 p.m.
Healthcare giant Abbott (NYSE:ABT) executed an unspecified number of layoffs at its Illinois headquarters, a local newspaper reported.
The U.S. Supreme Court denies stent pioneer Dr. Bruce Saffran's appeal of a $600 million patent infringement decision to Johnson & Johnson's Cordis stent-making arm.
Johnson & Johnson's (NYSE:JNJ) Cordis stent-making arm won the final round in a patent infringement battle with stent pioneer Dr. Bruce Saffran when the U.S. Supreme Court yesterday declined to hear Saffran's appeal.
Abbott's 4th-quarter and 2013 earnings per share meet expectations on Wall Street, but another revenue miss pushes shares down today.
FDA regulators issue the highest-risk Class I label over concerns that erroneous test results produced by some Abbott blood glucose testing strips may harm patients.